Access the full text.
Sign up today, get DeepDyve free for 14 days.
D. Alessi, A. Cuenda, Philip Cohen, D. Dudley, A. Saltiel (1995)
PD 098059 Is a Specific Inhibitor of the Activation of Mitogen-activated Protein Kinase Kinase in Vitro and in Vivo(*)The Journal of Biological Chemistry, 270
Zhen-yi Wang, Zhu Chen (2008)
Acute promyelocytic leukemia: from highly fatal to highly curable.Blood, 111 5
K. Yamakawa, T. Satoh (1981)
Studies on the Terpenoids and Related Alicyclic Compounds. XXVI. Total Syntheses of highly Oxygenated Furanoeremophilanes. : (±)-6β-Hydroxy-1, 10-dehydrofuranoeremophilan-9-one, (±)-Decompositin, (±)-Dihydrodecompositin, (±)-Adenostylone, (±)-3β, 6β-Dipropionyloxyeuryopsin-9-one,Chemical & Pharmaceutical Bulletin, 29
S. Kim, J. Song, B. Choi, Hyeoung-Joon Kim, T. Kim (2006)
Chemical Modification of Santonin into a Diacetoxy Acetal Form Confers the Ability to Induce Differentiation of Human Promyelocytic Leukemia Cells via the Down-regulation of NF-κB DNA Binding Activity*Journal of Biological Chemistry, 281
L. Degos, Z. Wang (2001)
All trans retinoic acid in acute promyelocytic leukemiaOncogene, 20
H. Beere, J. Hickman (1993)
Differentiation: a suitable strategy for cancer chemotherapy?Anti-cancer drug design, 8 4
T. Breitman, Stuart SELONICKt, J. Steven, COLLINSf (1980)
Induction of differentiation of the human promyelocytic leukemia cell line (HL-60) by retinoic acid.Proceedings of the National Academy of Sciences of the United States of America, 77 5
S. Kim, Sang-Mi Oh, T. Kim (2005)
Induction of human leukemia HL-60 cell differentiation via a PKC/ERK pathway by helenalin, a pseudoguainolide sesquiterpene lactone.European journal of pharmacology, 511 2-3
Chantal Mathieu, M. Jafari (2006)
Immunomodulation by 1,25-dihydroxyvitamin D3: therapeutic implications in hemodialysis and renal transplantation.Clinical nephrology, 66 4
E. Coligan (1991)
Current protocols in immunology
(2001)
Evidence that activation of MEK 1,2/erk 1,2 signal transduction pathway is necessary for calcitriol-induced differentiation of HL-60 cells
MB Miranda, TF McGuire, De Johnson (2002)
Importance of MEK-1/-2 signaling in monocytic and granulocytic differentiation of myeloid cell linesLeukemia, 16
Matthew Bennett, S. Sirrs, J. Yeung, Clayton Smith (2005)
Hypercalcemia due to all trans retinoic acid in the treatment of acute promyelocytic leukemia potentiated by voriconazoleLeukemia & Lymphoma, 46
T. Kim, B. Kang, M. Lee, Y. Choe, S. Hwang (2001)
Inhibition of interleukin‐12 production by auranofin, an anti‐rheumatic gold compound, deviates CD4+ T cells from the Th1 to the Th2 pathwayBritish Journal of Pharmacology, 134
(1997)
25-Dihydroxyvitamin D 3 induced activation and subsequent nuclear translocation of MAPK is upstream regulated by PKC in HL-60 cells
E. Marcinkowska, E. Marcinkowska, A. Wiedlocha, C. Radzikowski (1998)
Evidence that phosphatidylinositol 3-kinase and p70S6K protein are involved in differentiation of HL-60 cells induced by calcitriol.Anticancer research, 18 5A
Q. Pan, John Granger, Timothy O'Conneu, M. Somerman, Robert Simpson (1997)
Promotion of HL-60 cell differentiation by 1,25-dihydroxyvitamin D3 regulation of protein kinase C levels and activity.Biochemical pharmacology, 54 8
S. Collins, F. Ruscetti, R. Gallagher, R. Gallo (1979)
Normal functional characteristics of cultured human promyelocytic leukemia cells (HL-60) after induction of differentiation by dimethylsulfoxideThe Journal of Experimental Medicine, 149
(1998)
The anti-inflammatory sesquiterpene lactone arsantin inhibits the transcription factor NF-kappa B by directly targeting p65
F. Jamshidi, Jing Zhang, J. Harrison, Xuening Wang, G. Studzinski (2008)
Induction of differentiation of human leukemia cells by combinations of COX inhibitors and 1, 25-dihydroxyvitamin D3 involves Raf1 but not Erk 1/2 signalingCell Cycle, 7
S. Ishida, Yukari Shigemoto-mogami, Youichi Shinozaki, H. Kagechika, K. Shudo, S. Ozawa, J. Sawada, Y. Ohno, Kazuhide Inoue (2004)
Differential modulation of PI3-kinase/Akt pathway during all-trans retinoic acid- and Am80-induced HL-60 cell differentiation revealed by DNA microarray analysis.Biochemical pharmacology, 68 11
Yen-xia Ji, Andrzg Kutner, A. Verstuyf, L. Verlinden, G. Studzinski (2002)
Derivatives of Vitamins D2 and D3 Activate Three MAPK Pathways and Upregulate pRb Expression in Differentiating HL60 CellsCell Cycle, 1
Wilhelm Woessmann, Wilhelm Woessmann, N. Mivechi (2001)
Role of ERK activation in growth and erythroid differentiation of K562 cells.Experimental cell research, 264 2
M. Miyashita, Toshio Suzuki, M. Hoshino, A. Yoshikoshi (1998)
The Organoselenium-Mediated Reduction of α,β-Epoxy Ketones, α,β-Epoxy Esters, and Their Congeners to β-Hydroxy Carbonyl Compounds: Novel Methodologies for the Synthesis of Aldols and Their Analogues.ChemInform, 29
(2006)
Immunomodulation by 1,25dihydroxyvitamin
E. Corey, A. Hortmann (1963)
The total synthesis of dihydrocostunolide.Journal of the American Chemical Society, 87 24
Hirofumi Tanaka, E. Abe, C. Miyaura, Y. Shiina, T. Suda (1983)
1 alpha,25-dihydroxyvitamin D3 induces differentiation of human promyelocytic leukemia cells (HL-60) into monocyte-macrophages, but not into granulocytes.Biochemical and biophysical research communications, 117 1
Q. Wang, Hagar Salman, M. Danilenko, G. Studzinski (2005)
Cooperation between antioxidants and 1,25‐dihydroxyvitamin D3 in induction of leukemia HL60 cell differentiation through the JNK/AP‐1/Egr‐1 pathwayJournal of Cellular Physiology, 204
K. Yamakawa, K. Nishitani (1976)
Studies on the Terpenoids and related Alicyclic Compounds. VIII. Chemical Transformation of α-Santonin into Arsantin and ArsaninChemical & Pharmaceutical Bulletin, 24
S. Kim, M. Danilenko, T. Kim (2008)
Differential enhancement of leukaemia cell differentiation without elevation of intracellular calcium by plant‐derived sesquiterpene lactone compoundsBritish Journal of Pharmacology, 155
M. Nishikawa, S. Shirakawa (1992)
The expression and possible roles of protein kinase C in haematopoietic cells.Leukemia & lymphoma, 8 3
Siyuan Zhang, Y. Won, C. Ong, Han-Ming Shen (2005)
Anti-cancer potential of sesquiterpene lactones: bioactivity and molecular mechanisms.Current medicinal chemistry. Anti-cancer agents, 5 3
S. Kim, So Kang, Hyeoung-Joon Kim, T. Kim (2002)
Potentiation of 1,25-dihydroxyvitamin D(3)-induced differentiation of human promyelocytic leukemia cells into monocytes by costunolide, a germacranolide sesquiterpene lactone.Biochemical pharmacology, 64 8
C. Chomienne, N. Balitrand, H. Cost, L. Degos, J. Abita (1986)
Structure-activity relationships of aromatic retinoids on the differentiation of the human histiocytic lymphoma cell line U-937.Leukemia research, 10 11
V. Honwad, E. Siscovic, A. Rao (1967)
Terpenoids—C: Synthesis of tauremisin (vulgarin), and saussurea lactoneTetrahedron, 23
(2006)
The histone deacetylase inhibitor FK228 distinctly sensitizes the human leukemia cells to retinoic acidinduced differentiation
F. Komada, M. Nishikawa, Y. Uemura, K. Morita, H. Hidaka, S. Shirakawa (1991)
Expression of three major protein kinase C isozymes in various types of human leukemic cells.Cancer research, 51 16
Sesquiterpene lactone compounds have received considerable attention in pharmacological research due to their therapeutic effects including anti-cancer and anti-inflammatory activities. In this report, we investigated the effect of arsantin, a sesquiterpene lactone compound present in Artemisia santolina , on cellular differentiation in the human promyelocytic leukemia HL-60 cell culture system. Arsantin significantly induced HL-60 cell differentiation in a concentration-dependent manner. Cytofluorometric analysis indicated that arsantin induced HL-60 cell differentiation predominantly into granulocytes. Both PKC and MAPK inhibitors suppressed the HL-60 cell differentiation induced by arsantin. Moreover, treatment with arsantin increased protein levels of PKCα and PKCβII isoforms, and also induced increased protein levels and phosphorylation form of MAPKs in HL-60 cells. Importantly, arsantin synergistically enhanced differentiation of HL-60 cells in a dose-dependent manner when combined with either low doses of 1,25-(OH) 2 D 3 or ATRA. The ability to enhance the differentiation potential of 1,25-(OH) 2 D 3 or ATRA by arsantin may improve outcomes in the therapy of acute promyelocytic leukemia.
Archives of Pharmacal Research – Springer Journals
Published: Nov 1, 2015
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.